Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Philip J. Budge"'
Autor:
Linda Djune-Yemeli, Marla Hertz, Hugues C. Nana-Djeunga, Amy Rush, Petra Erdmann-Gilmore, Robert Sprung, Jean Gabin Bopda, Reid Townsend, Palmer Masumbe Netongo, Joseph Kamgno, Philip J. Budge
Publikováno v:
Frontiers in Parasitology, Vol 2 (2023)
Background and methodsCirculating Loa loa antigens are often detected in individuals with heavy L. loa infections by diagnostic tests for lymphatic filariasis (LF) caused by Wuchereria bancrofti. This is a major challenge to LF mapping and eliminatio
Externí odkaz:
https://doaj.org/article/0588a95841d44a9baa974eee7f52664a
Autor:
Devyn Yates, Lucia S. Di Maggio, Bruce A. Rosa, Robert W. Sprung, Petra Erdmann-Gilmore, R. Reid Townsend, Philip J. Budge, Joseph Kamgno, Makedonka Mitreva, Gary J. Weil, Peter U. Fischer
Publikováno v:
Frontiers in Parasitology, Vol 2 (2023)
BackgroundImproved diagnostic tools are needed for detecting active filarial infections in humans. Tests are available that detect adult W. bancrofti circulating filarial antigen, but there are no sensitive and specific biomarker tests for brugian fi
Externí odkaz:
https://doaj.org/article/664a178a13a740d4ba347c475f01d58d
Autor:
Catherine M Bjerum, Benjamin G Koudou, Allassane F Ouattara, Daphne Lew, Charles W Goss, Pascal T Gabo, Christopher L King, Peter U Fischer, Gary J Weil, Philip J Budge
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 9, p e0011633 (2023)
BackgroundMoxidectin is a macrocyclic lactone registered for the treatment of human onchocerciasis. The drug has a good safety profile, large volume of distribution and a long elimination half-life. This paper reports tolerability data from the first
Externí odkaz:
https://doaj.org/article/700673892a3b44b5a4de81b30bb18bb0
Autor:
Yashpal S Chhonker, Catherine Bjerum, Veenu Bala, Allassane F Ouattara, Benjamin G Koudou, Toki P Gabo, Abdullah Alshehri, Abdoulaye Meïté, Peter U Fischer, Gary J Weil, Christopher L King, Philip J Budge, Daryl J Murry
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 8, p e0011567 (2023)
Moxidectin (MOX) is a milbemycin endectocide recently approved by the U.S. FDA for the treatment of onchocerciasis in persons at least 12 years of age. MOX has been shown to have a good safety profile in recent clinical trials. The efficacy of MOX fo
Externí odkaz:
https://doaj.org/article/45c8d8f3e90f418f857ef227ccaa3519
Autor:
C. William Wester, Bryan E. Shepherd, Usman J. Wudil, Baba Maiyaki Musa, Donna J. Ingles, Heather L. Prigmore, Faisal S. Dankishiya, Aima A. Ahonkhai, Bukar A. Grema, Philip J. Budge, Ayumi Takakura, Opeyemi A. Olabisi, Cheryl A. Winkler, Jeffrey B. Kopp, Joseph V. Bonventre, Christina M. Wyatt, Muktar H. Aliyu
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-17 (2022)
Abstract Background Microalbuminuria is an independent risk factor for cardiovascular and kidney disease and a predictor of end organ damage, both in the general population and in persons with HIV (PWH). Microalbuminuria is also an important risk fac
Externí odkaz:
https://doaj.org/article/7f7310b716ec4421be479d015ca124c3
Autor:
Rachel E. Bosserman, Christopher W. Farnsworth, Caroline A. O’Neil, Candice Cass, Daniel Park, Claire Ballman, Meghan A. Wallace, Emily Struttmann, Henry Stewart, Olivia Arter, Kate Peacock, Victoria J. Fraser, Philip J. Budge, Margaret A. Olsen, Carey-Ann D. Burnham, Hilary M. Babcock, Jennie H. Kwon, for the CDC Prevention Epicenters
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Objective: To determine the prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG nucleocapsid (N) antibodies among healthcare personnel (HCP) with no prior history of COVID-19 and to identify factors associated with s
Externí odkaz:
https://doaj.org/article/002815063179414c9efb6253f98afc47
Autor:
Sarah E Greene, Kerstin Fischer, Young-Jun Choi, Kurt C Curtis, Philip J Budge, Makedonka Mitreva, Christopher L King, Peter U Fischer, Gary J Weil
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 5, p e0010407 (2022)
BackgroundLymphatic filariasis (LF) is a neglected tropical disease caused by the filarial nematodes Wuchereria bancrofti, Brugia malayi and Brugia timori. The Global Program to Eliminate LF uses mass drug administration (MDA) of anti-filarial drugs
Externí odkaz:
https://doaj.org/article/037ce7b364d84a7baf714c88d408a2f6
Autor:
Rachel E. Bosserman, Christopher W. Farnsworth, Caroline A. O’Neil, Candice Cass, Daniel Park, Claire Ballman, Meghan A. Wallace, Emily Struttmann, Henry Stewart, Olivia Arter, Kate Peacock, Victoria J. Fraser, Philip J. Budge, Margaret A. Olsen, Carey-Ann D. Burnham, Hilary M. Babcock, Jennie H. Kwon, for the CDC Prevention Epicenters
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14–28 days after
Externí odkaz:
https://doaj.org/article/9b04a25b79924f0fa6e2770940fd9882
Autor:
Jennie H. Kwon, Philip J. Budge, Caroline A. O’Neil, Kate Peacock, Eva M. Aagaard, Victoria J. Fraser, Margaret A. Olsen, Hilary Babcock, for the CDC Prevention Epicenters Program
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Abstract Objective: To identify characteristics associated with positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) tests in healthcare personnel. Design: Retrospective cohort study. Setting: A mult
Externí odkaz:
https://doaj.org/article/df6b9e7c0a244b678d70a5c9bb92514c
Autor:
John Horton, Ute Klarmann-Schulz, Mariana Stephens, Philip J. Budge, Yaya Coulibaly, Alex Debrah, Linda Batsa Debrah, Suma Krishnasastry, Upendo Mwingira, Abdallah Ngenya, Samuel Wanji, Mirani Weerasooriya, Channa Yahathugoda, Inge Kroidl, Drew Deathe, Andrew Majewski, Sarah Sullivan, Charles Mackenzie, Thomas B. Nutman, Joseph P. Shott, Gary Weil, Eric Ottesen, Achim Hoerauf
Publikováno v:
Parasites & Vectors, Vol 13, Iss 1, Pp 1-11 (2020)
Abstract Background As new lymphatic filariasis infections are eliminated through mass chemotherapy, previously affected individuals are left with the sequellae, especially chronic progressive lymphoedema. Currently this is managed by careful attenti
Externí odkaz:
https://doaj.org/article/7af8c8f093dc433f8fbbf9b5f0066a14